Metabolism Is a Flow Problem

Oct 3

8 min read

What a New Mitochondrial Transporter Reveals About Cycling, Congestion, and Bioenergetic Impedance

We often talk about metabolism as if it were a collection of separate pathways: glucose is burned, fat is stored, fat is oxidized, mitochondria make ATP.

But metabolism is not a set of isolated reactions. It is flow.

Carbon must enter cells, move between compartments, cycle through biochemical pathways, cross mitochondrial membranes, be transformed, exported, recycled, and eventually converted into useful biological work. When that movement is well coordinated, cells can rapidly adjust to changing demand. When one part of the system becomes limiting, however, substrates and intermediates can accumulate upstream while becoming deficient downstream.

A new study published in Science provides an unusually clear example of this principle.

Karavaeva and colleagues identified the mitochondrial carrier SLC25A34 as an important regulator of lipid metabolism in brown adipose tissue. The transporter integrates signals from the circadian clock, environmental temperature, and nutrient availability, allowing brown fat to coordinate when it builds fat and when it burns it.

At first glance, this sounds like another story about a “fat-burning switch.”

The biology is much more interesting.

Brown fat builds fat in order to burn fat

Brown adipose tissue specializes in converting chemical energy into heat. During cold exposure, its mitochondria dramatically increase substrate oxidation and thermogenesis.

One might therefore expect active brown fat simply to break down stored fat.

Instead, brown adipocytes do something that initially appears wasteful: they synthesize new lipids while simultaneously breaking down and oxidizing lipids.

This is sometimes described as a futile lipid cycle.

But “futile” can be misleading.

Running synthesis and breakdown together consumes energy, generates heat, helps clear circulating glucose and lipid, and appears to maintain the cellular machinery required for rapid oxidative metabolism. In an actively thermogenic tissue, cycling itself can therefore be functional.

The new study shows that SLC25A34 helps keep this cycle moving.

During the resting phase, REV-ERB transcriptional repressors suppress Slc25a34. As animals enter their active phase, this inhibition falls. Cold can override the circadian brake, while lipid-related signals stimulate expression through PPAR pathways. Remarkably, cold exposure increased SLC25A34 expression in mouse brown fat by about 90-fold.

Thus, very different signals—

time of day, temperature, fasting, dietary fat and metabolic demand

—converge on a mitochondrial transporter.

That alone should make us pay attention.

A second cycle runs underneath the lipid cycle

The deeper finding concerns oxaloacetate, or OAA.

For lipid synthesis to proceed, mitochondria export carbon that can be used to generate cytosolic acetyl-CoA. Citrate is one familiar route, while this study also implicates N-acetylaspartate-related carbon transfer.

But exporting carbon generates another problem: the mitochondrial and cytosolic pools must remain balanced.

SLC25A34 is proposed to help solve this by transporting OAA back into mitochondria. The published Science paper is appropriately cautious here: direct OAA transport by purified SLC25A34 has not yet been demonstrated, so OAA remains the strongly supported proposed substrate rather than a definitively established one.

Conceptually, however, the architecture is fascinating.

One cycle is occurring at the level of lipid:

acetyl-CoA → lipid synthesis → triglyceride → lipolysis → fatty acids → mitochondrial oxidation

while another cycle helps move carbon between compartments:

mitochondrial carbon → exported citrate/N-acetylaspartate → cytosolic acetyl-CoA + OAA → OAA return to mitochondria

These cycles operate in parallel and support one another.

The OAA cycle helps sustain the carbon movement required for lipid cycling, while lipid cycling supports thermogenic substrate oxidation.

In other words, the cell does not merely need fuel.

It needs continuous circulation of fuel and intermediates through the correct compartments.

When flow is interrupted, the system goes down

This becomes particularly clear when SLC25A34 is reduced.

The investigators found that OAA accumulated outside mitochondria while becoming relatively depleted inside them. Cytosolic acetyl-CoA production declined. Lipogenesis from glucose decreased. Mitochondrial respiratory capacity fell, and expression of genes supporting oxidative metabolism was reduced.

This is important.

The initiating problem was not simply destruction of the electron transport chain.

Instead, disturbance of a transport and recycling step propagated through the metabolic network until mitochondrial oxidative capacity itself declined.

Supplying acetate—an alternative source from which cells can generate acetyl-CoA—partially rescued the respiratory phenotype in the experimental system, further supporting the idea that disrupted carbon routing contributes to the downstream mitochondrial defect.

This gives us a different way to think about mitochondrial metabolism.

Rather than asking only:

Are the mitochondria functioning?

we should sometimes ask:

Can substrates and intermediates move through the mitochondrial system fast enough to meet demand?

These are not the same question.

Metabolism is governed by conductance as well as supply

A biochemical pathway can contain abundant substrate and intact enzymes yet still have poor overall throughput if an intermediate cannot move efficiently from one compartment to another.

This is particularly important for mitochondria because the inner mitochondrial membrane is highly selective.

Carbon skeletons, fatty-acid derivatives, nucleotides, phosphate, amino-acid intermediates and other metabolites cannot simply diffuse freely between the cytosol and mitochondrial matrix. Their movement depends on specialized transport systems.

These transporters therefore act as gates of metabolic conductance.

If transport capacity matches demand, metabolites circulate and metabolic cycles remain coordinated.

But imagine demand increasing faster than transport capacity.

Upstream:

substrates and intermediates accumulate.

Downstream:

the same system can become functionally substrate-deficient.

Thus, congestion and deficiency can occur simultaneously—on opposite sides of the same bottleneck.

That is a useful way to understand metabolic congestion.

Substrate congestion does not necessarily mean “too much food”

We previously proposed substrate congestion as a state in which carbon and reducing equivalents enter metabolic pathways faster than they can be efficiently processed and cleared.

The SLC25A34 study adds an important layer to this concept.

Congestion does not have to arise only because too much glucose or fat enters the cell.

It can also emerge because the pathways that transport, recycle, transform or remove metabolic intermediates become limiting.

The relevant relationship is therefore not simply:

high substrate = congestion.

It is:

substrate pressure relative to throughput capacity = risk of congestion.

A metabolically flexible system may handle a large substrate load with little difficulty because its transporters, TCA cycle, redox systems, respiratory machinery and downstream demand are capable of maintaining flow.

The same substrate load may become problematic when one of those conductance steps is constrained.

Under those conditions:

input continues → clearance slows → intermediates accumulate → compensatory pathways are recruited → metabolic routing changes → effective throughput declines.

What initially looks like excess can therefore actually be a problem of insufficient conductance.

Futile cycling may actually be evidence of high metabolic flexibility

The study also challenges another common assumption.

Metabolic efficiency is often imagined as minimizing unnecessary reactions.

Biology does not always work that way.

Running apparently opposing reactions simultaneously—such as lipid synthesis and lipid oxidation—allows a system to respond rapidly, dissipate energy, maintain pathway readiness and adjust metabolic output without waiting for entire pathways to switch on or off.

Under healthy conditions, such cycling can therefore be a feature of high metabolic throughput and flexibility.

The problem is not cycling itself.

The problem emerges when the system can no longer sustain the flow needed to complete the cycle.

A useful distinction is:

successful cycling → substrates circulate → demand is met → recovery remains possible

versus

constrained cycling → intermediates accumulate or become misdistributed → compensatory rerouting increases → throughput falls.

This is where the findings connect to our broader concept of bioenergetic impedance.

From metabolic congestion to bioenergetic impedance

In our recently published Network Physiology perspective, we defined bioenergetic impedance as a time-dependent constraint on energetic throughput and recovery that arises when energetic pressure exceeds available biological capacity. It is not another name for mitochondrial dysfunction, inflammation, insulin resistance, lactate accumulation, or any single metabolic abnormality.

Instead, it asks about the relationship between:

demand → conductance → throughput → compensation → recovery.

The SLC25A34 findings provide a useful mechanistic illustration.

Consider the sequence:

greater thermogenic demand→ greater substrate mobilization and carbon flow→ greater requirement for mitochondrial–cytosolic metabolite cycling→ greater requirement for OAA transport→ transporter capacity becomes important for maintaining flow.

If that conductance step becomes inadequate:

metabolite movement slows→ carbon becomes misdistributed→ lipid cycling declines→ compensatory pathways change→ mitochondrial respiratory capacity falls→ energetic output becomes increasingly constrained.

In the language of bioenergetic impedance, the critical issue is not whether SLC25A34 itself is impedance.

It is not.

Rather, transporter limitation represents one possible determinant of conductance that can contribute to a demand–throughput mismatch.

Substrate congestion may then be one manifestation of that mismatch, while metabolic rerouting represents an adaptive attempt to work around it.

If the constraint resolves, normal flow can recover.

If it persists, compensatory pathways may become increasingly necessary, recovery incomplete, and effective impedance greater.

That distinction matters because our framework specifically separates the initiating constraint, the compensatory response, and the resulting state of impaired throughput.

Mitochondrial dysfunction may sometimes be downstream of impaired flow

This also raises an important conceptual possibility.

We frequently observe reduced mitochondrial respiration and conclude that dysfunctional mitochondria caused the metabolic problem.

Sometimes that will certainly be true.

But the causal direction does not always have to begin at the respiratory chain.

A defect in substrate delivery, mitochondrial transport, metabolite recycling, redox balance or carbon clearance can progressively reduce mitochondrial utilization and adaptive capacity.

The apparent “mitochondrial dysfunction” measured later may therefore partly reflect the downstream consequences of prolonged disturbance of metabolic flow.

The SLC25A34 experiment illustrates this principle particularly well: disturbing a metabolite transport route eventually suppresses respiration and oxidative programs.

This does not prove that transporter congestion explains mitochondrial dysfunction broadly across disease. But it demonstrates that the causal architecture is biologically plausible.

Mitochondrial membranes may be major control points for metabolic flow

There is a broader lesson here.

Mitochondria are often drawn in metabolic diagrams as boxes into which substrates enter and ATP emerges.

Real mitochondria are much more constrained.

Their membranes create compartments, and those compartments require carefully regulated molecular traffic.

Transporters therefore determine which substrates can enter, which intermediates can leave, how rapidly carbon can be recycled, and whether metabolic pathways on opposite sides of the membrane remain synchronized.

The University of Copenhagen investigators themselves note that the functions of many mitochondrial transporters remain unknown. SLC25A34 was one of them until this work revealed its unexpected role connecting circadian timing, diet, temperature and lipid metabolism.

There may therefore be considerable biology hidden not just in metabolic enzymes, but in the traffic between them.

From pathways to flow

For decades, metabolism has often been taught as arrows between metabolites.

The emerging picture is more dynamic.

The arrows themselves matter.

Their capacity matters.

Their timing matters.

Their direction matters.

And critically, their ability to keep moving under increasing demand matters.

This leads to a different way of thinking about metabolic health:

metabolic health is not simply having enough substrate or enough mitochondria. It is the capacity to keep substrates, electrons and metabolic intermediates moving through a coordinated system—and to restore that flow after challenge.

The SLC25A34 study gives us a beautiful molecular example.

OAA cycling supports carbon routing.

Carbon routing supports lipid cycling.

Lipid cycling supports thermogenic oxidation.

And the whole system depends on enough transport capacity to keep those cycles moving.

When flow is maintained, seemingly “futile” cycling can support flexibility and high throughput.

When flow becomes constrained, intermediates redistribute, cycling slows, compensatory rerouting becomes necessary, and downstream oxidative capacity can decline.

That is the progression from flow → constraint → congestion → compensation.

Whether the system subsequently recovers—or remains trapped under persistent constraint—is where the broader concept of bioenergetic impedance becomes relevant.

Sometimes the problem may not be that metabolism has run out of fuel.

The problem may be that the fuel can no longer move.